Cargando…

Validation of PhageDx™ Cronobacter Assay for the Identification of Cronobacter Spp. in Powdered Infant Formula: AOAC Performance Tested Method(SM) 051803

BACKGROUND: The PhageDx(™)Cronobacter Assay is based on the infection of Cronobacter spp. by specific bacteriophages and expression of a luciferase reporter gene. Results are generated in as little as 18.5 h for powdered infant formula (PIF). OBJECTIVE: An AOAC Performance Tested Methods(SM) (PTM) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Erickson, Stephen, Gil, Jose, Stach, Jessica, Hahn, Wendy, Nguyen, Minh M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665749/
https://www.ncbi.nlm.nih.gov/pubmed/33734363
http://dx.doi.org/10.1093/jaoacint/qsab038
_version_ 1784614073068945408
author Erickson, Stephen
Gil, Jose
Stach, Jessica
Hahn, Wendy
Nguyen, Minh M
author_facet Erickson, Stephen
Gil, Jose
Stach, Jessica
Hahn, Wendy
Nguyen, Minh M
author_sort Erickson, Stephen
collection PubMed
description BACKGROUND: The PhageDx(™)Cronobacter Assay is based on the infection of Cronobacter spp. by specific bacteriophages and expression of a luciferase reporter gene. Results are generated in as little as 18.5 h for powdered infant formula (PIF). OBJECTIVE: An AOAC Performance Tested Methods(SM) (PTM) study was conducted to validate the PhageDx Cronobacter Assay for the detection of Cronobacter in 10, 100, and 300 g milk- and soy-based PIF test portions. METHOD: The performance of the PhageDx method was compared to the ISO 22964:2006/2017 Microbiology of the Food Chain—Horizontal Method for the Detection of Cronobacter spp. and the U.S. Food and Drug Administration (FDA) Bacteriological Analytical Manual (BAM) Chapter 29 Cronobacter: 2012. Inclusivity/exclusivity, product consistency and stability, and robustness testing also were conducted. RESULTS: There was no significant difference between the 10, 100, or 300 g test portions for the milk and soy PIF matrixes between the PhageDx Cronobacter Assay, the ISO 22964:2006/2017, and the FDA BAM Chapter 29 Cronobacter: 2012 methods. The reporter bacteriophages were specific for Cronobacter and infected 75 strains in inclusivity testing. They did not infect 35 non-Cronobacter bacteria in exclusivity testing. Robustness testing showed that the method performed well with specific deviations from the standard protocol. Consistency and stability testing demonstrated that the recombinant phage gave consistent results across three production lots and was stable when stored under appropriate conditions for at least 3 months. CONCLUSIONS: Work in the submitting and independent laboratories demonstrated that the PhageDx Cronobacter Assay meets the qualifications for PTM status. HIGHLIGHTS: The PhageDx Cronobacter Assay is a rapid, simple, and specific test that has shown equivalence to both the FDA BAM and ISO reference methods for detecting Cronobacter spp. in PIF.
format Online
Article
Text
id pubmed-8665749
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86657492021-12-28 Validation of PhageDx™ Cronobacter Assay for the Identification of Cronobacter Spp. in Powdered Infant Formula: AOAC Performance Tested Method(SM) 051803 Erickson, Stephen Gil, Jose Stach, Jessica Hahn, Wendy Nguyen, Minh M J AOAC Int Microbiological Methods BACKGROUND: The PhageDx(™)Cronobacter Assay is based on the infection of Cronobacter spp. by specific bacteriophages and expression of a luciferase reporter gene. Results are generated in as little as 18.5 h for powdered infant formula (PIF). OBJECTIVE: An AOAC Performance Tested Methods(SM) (PTM) study was conducted to validate the PhageDx Cronobacter Assay for the detection of Cronobacter in 10, 100, and 300 g milk- and soy-based PIF test portions. METHOD: The performance of the PhageDx method was compared to the ISO 22964:2006/2017 Microbiology of the Food Chain—Horizontal Method for the Detection of Cronobacter spp. and the U.S. Food and Drug Administration (FDA) Bacteriological Analytical Manual (BAM) Chapter 29 Cronobacter: 2012. Inclusivity/exclusivity, product consistency and stability, and robustness testing also were conducted. RESULTS: There was no significant difference between the 10, 100, or 300 g test portions for the milk and soy PIF matrixes between the PhageDx Cronobacter Assay, the ISO 22964:2006/2017, and the FDA BAM Chapter 29 Cronobacter: 2012 methods. The reporter bacteriophages were specific for Cronobacter and infected 75 strains in inclusivity testing. They did not infect 35 non-Cronobacter bacteria in exclusivity testing. Robustness testing showed that the method performed well with specific deviations from the standard protocol. Consistency and stability testing demonstrated that the recombinant phage gave consistent results across three production lots and was stable when stored under appropriate conditions for at least 3 months. CONCLUSIONS: Work in the submitting and independent laboratories demonstrated that the PhageDx Cronobacter Assay meets the qualifications for PTM status. HIGHLIGHTS: The PhageDx Cronobacter Assay is a rapid, simple, and specific test that has shown equivalence to both the FDA BAM and ISO reference methods for detecting Cronobacter spp. in PIF. Oxford University Press 2021-03-18 /pmc/articles/PMC8665749/ /pubmed/33734363 http://dx.doi.org/10.1093/jaoacint/qsab038 Text en © AOAC INTERNATIONAL 2021. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Microbiological Methods
Erickson, Stephen
Gil, Jose
Stach, Jessica
Hahn, Wendy
Nguyen, Minh M
Validation of PhageDx™ Cronobacter Assay for the Identification of Cronobacter Spp. in Powdered Infant Formula: AOAC Performance Tested Method(SM) 051803
title Validation of PhageDx™ Cronobacter Assay for the Identification of Cronobacter Spp. in Powdered Infant Formula: AOAC Performance Tested Method(SM) 051803
title_full Validation of PhageDx™ Cronobacter Assay for the Identification of Cronobacter Spp. in Powdered Infant Formula: AOAC Performance Tested Method(SM) 051803
title_fullStr Validation of PhageDx™ Cronobacter Assay for the Identification of Cronobacter Spp. in Powdered Infant Formula: AOAC Performance Tested Method(SM) 051803
title_full_unstemmed Validation of PhageDx™ Cronobacter Assay for the Identification of Cronobacter Spp. in Powdered Infant Formula: AOAC Performance Tested Method(SM) 051803
title_short Validation of PhageDx™ Cronobacter Assay for the Identification of Cronobacter Spp. in Powdered Infant Formula: AOAC Performance Tested Method(SM) 051803
title_sort validation of phagedx™ cronobacter assay for the identification of cronobacter spp. in powdered infant formula: aoac performance tested method(sm) 051803
topic Microbiological Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665749/
https://www.ncbi.nlm.nih.gov/pubmed/33734363
http://dx.doi.org/10.1093/jaoacint/qsab038
work_keys_str_mv AT ericksonstephen validationofphagedxcronobacterassayfortheidentificationofcronobactersppinpowderedinfantformulaaoacperformancetestedmethodsm051803
AT giljose validationofphagedxcronobacterassayfortheidentificationofcronobactersppinpowderedinfantformulaaoacperformancetestedmethodsm051803
AT stachjessica validationofphagedxcronobacterassayfortheidentificationofcronobactersppinpowderedinfantformulaaoacperformancetestedmethodsm051803
AT hahnwendy validationofphagedxcronobacterassayfortheidentificationofcronobactersppinpowderedinfantformulaaoacperformancetestedmethodsm051803
AT nguyenminhm validationofphagedxcronobacterassayfortheidentificationofcronobactersppinpowderedinfantformulaaoacperformancetestedmethodsm051803